EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trif, M.
Right arrow Articles by Brock, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trif, M.
Right arrow Articles by Brock, J. H.
Experimental Biology and Medicine 226:559-564 (2001)
© 2001 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Liposomes as Possible Carriers for Lactoferrin in the Local Treatment of Inflammatory Diseases

Mihaela Trif*,1, Cristina Guillen{dagger}, Diane M. Vaughan{dagger}, Joan M. Telfer{dagger}, James M. Brewer{dagger}, Anca Roseanu* and Jeremy H. Brock{dagger}

* Institute of Biochemistry, 77700 Bucharest, Romania;
{dagger} Department of Immunology, University of Glasgow, Western Infirmary, Glasgow G11 6NT, Scotland, United Kingdom

Liposomes prepared from naturally occurring biodegradable and nontoxic lipids are good candidates for local delivery of therapeutic agents. Treatment of arthritis by intra-articular administration of anti-inflammatory drugs encapsulated in liposomes prolongs the residence time of the drug in the joint. We have previously shown that intra-articular injection of human lactoferrin (hLf), a glycoprotein that possesses anti-inflammatory and antimicrobial activities, into mice with collagen-induced arthritis reduces inflammation. We have now investigated the possibility of using liposome-entrapped hLf as a delivery system to prolong hLf retention at sites of local inflammation such as the rheumatoid joint. Entrapment of hLf in negatively charged liposomes enhanced its accumulation in cultured human synovial fibroblasts from rheumatoid arthritis (RA) patients, compared with positively charged formulations or free protein. However, in the presence of synovial fluid, positively charged liposomes with entrapped hLf were more stable than the negatively charged formulations. In vivo experiments in mice with collagen-induced arthritis showed that the positive liposomes were more efficient in prolonging the residence time of hLf in the inflamed joint as compared with other liposomes. Thus, the amount of hLf retained in the joint after 2 hr was 60% of the injected dose in the case of positive liposomes and only 16% for negative pH-sensitive liposomes. The results suggest that entrapment of hLf in positively charged liposomes may modify its pharmacodynamic profile and be of therapeutic benefit in the treatment of RA and other local inflammatory conditions.

Key Words: liposomes • human lactoferrin • rheumatoid arthritis • human synovial fibroblasts • human synovial fluid




This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
S. H. Wong, N. Francis, H. Chahal, K. Raza, M. Salmon, D. Scheel-Toellner, and J. M. Lord
Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid
Rheumatology, January 1, 2009; 48(1): 39 - 44.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.